J Neurochem 96 : 179194
That is the whole story, start to finish: a stubborn idea from 1975, a researcher who spent his life on it, a compound that healed everything in rats, a human trial whose result nobody saw for twenty years, a molecule no company can own so no company will finish testing, and a stack of the most basic questions is it safe, at what dose, made by whom, and how does it actually work that still have no answers
Reviews of retro-inverso peptides describe this design as a peptide chemistry strategy often studied for stability and molecular recognition questions [5]
These values, established in Erik M.P
However, the overall results depend on the consistency of treatment and maintaining healthy lifestyle habits
Bacterial suspensions for infection were plated in solid agar medium to confirm the CFUs used for in vivo challenges